MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$498,260
Unit: Dollar
Positive Cash Flow Breakdown
Accounts payable and accrued exp...
Prepaid insurance
Interest income
Others
Negative Cash Flow Breakdown
Operating expenses
Salaries
Insurance
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
308,747
141,597
257,197
187,808
Salaries
125,000
125,000
275,000
125,000
Insurance
63,414
68,919
70,369
214,970
Stock-based compensation
8,253
23,505
45,674
87,180
Operating expenses
302,800
445,768
88,334
242,297
Interest income
34,512
38,801
51,931
47,325
Net loss
-773,702
-765,988
-684,643
-666,737
Stock-based compensation
8,253
23,505
45,674
87,180
Change in fair value of warrant liability
108
-265
-498
-1,212
Advances on research and development contract services
-
-
11,314
-11,314
Prepaid insurance
-44,263
-62,419
-35,233
-
Interest receivable
-823
-2,086
9,895
-
Prepaid insurance and prepaid expenses
-
-
-
-71,347
Prepaid financing costs
709
51,957
-
-
Accounts payable and accrued expenses
202,524
-74,082
84,803
-70,648
Net cash used in operating activities
-518,440
-804,282
-714,762
-591,384
Proceeds from issuance of common shares from atm, net of costs
-
-
0
0
Proceeds from issuance of common shares from atm, net of costs
20,180
-
0
0
Net cash provided by financing activities
20,180
-
0
0
Net increase (decrease) in cash
-498,260
-804,282
-714,762
-591,384
Cash, beginning of period
4,530,040
5,334,322
6,049,084
3,325,131
Cash, end of period
4,031,780
4,530,040
5,334,322
6,049,084
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
common shares from atm,...
$20,180
(-99.54%↓ Y/Y)
Net cash provided by
financing activities
$20,180
(-99.57%↓ Y/Y)
Net increase
(decrease) in cash
-$498,260
(-115.03%↓ Y/Y)
Canceled cashflow
$20,180
Accounts payable and
accrued expenses
$202,524
(163.46%↑ Y/Y)
Prepaid insurance
-$44,263
Stock-based compensation
$8,253
(-93.32%↓ Y/Y)
Interest receivable
-$823
Change in fair value of
warrant liability
$108
(104.79%↑ Y/Y)
Net cash used in
operating activities
-$518,440
(62.57%↑ Y/Y)
Canceled cashflow
$255,971
Interest income
$34,512
(29.28%↑ Y/Y)
Net loss
-$773,702
(55.98%↑ Y/Y)
Canceled cashflow
$34,512
Prepaid financing costs
$709
Research and development
$308,747
(-49.81%↓ Y/Y)
Operating expenses
$302,800
(-53.59%↓ Y/Y)
Salaries
$125,000
(-50.00%↓ Y/Y)
Insurance
$63,414
(-55.71%↓ Y/Y)
Stock-based compensation
$8,253
(-93.32%↓ Y/Y)
Buy us a coffee
Bone Biologics Corp (BBLGW)
Bone Biologics Corp (BBLGW)